Clinical Trial Applications: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | |
|---|---|---|---|---|
421. |
ECCT/13/10/01 | Clinical Trial of Acceptability, Adherence and Biologic Effects of a Vaginal Contraceptive Ring among Women in Western Kenya |
Principal Investigator(s) 1. Fredrick Odhiambo Otieno 2. Lisa Ann Mills Site(s) in Kenya KEMRI/CDC Research and Public Health Collaboration |
View |
422. |
ECCT/13/08/06 | Management of myocardial injury After NoncArdiac surgGEry (MANAGE) Trial |
Principal Investigator(s) 1. GERALD OCHIENG\' YONGA 2. LEONARD MZEE NGUNGA Site(s) in Kenya Aga Khan University Hospital, Nairobi |
View |
423. |
ECCT/13/08/02 | MalPaC Trial Comparing drug-regimens for clearing parasites in Phase IIb trial designs prior to PCR monitoring for Plasmodium falciparum infection. |
Principal Investigator(s) 1. Caroline Amolo Ogwang 2. Francis Maina Ndung\'u Site(s) in Kenya Junju |
View |
424. |
ECCT/13/08/01 | M72/AS01 E A phase IIb, double-blind, randomised, placebo-controlled study to evaluate the efficacy, safety and immunogenicity of GSK Biologicals’ candidatetuberculosis (TB) vaccine GSK 692342 against TB disease, in healthy adults aged 18-50 years, living in a TB endemic region. |
Principal Investigator(s) 1. Dr Videlis Nduba Site(s) in Kenya KEMRI-CDC |
View |
425. |
ECCT/13/07/05 | Single Dose Escalating, Single-blind Phase 1 Trial in Healthy Male Volunteers to Evalute the Safety, Tolerability and the Pharmacokinetics of Oleylphosphocholine. |
Principal Investigator(s) 1. Rashid Ravasco Juma Site(s) in Kenya KEMRI Centre for Clinical Research |
View |